InvestorsHub Logo
Followers 103
Posts 13776
Boards Moderated 1
Alias Born 01/23/2004

Re: Myth post# 59586

Tuesday, 08/30/2022 1:58:36 PM

Tuesday, August 30, 2022 1:58:36 PM

Post# of 65997
Myth

Gabapentin and "SOHM, Inc., has signed agreements with various ANDA holders to license products under the SOHM private label for distribution in the United States. New products include Colsevelam Hydrochloride, used to lower high cholesterol levels in the blood. Topiramate, an anticonvulsant drug used in the control of epilepsy and in the prophylaxis and treatment of migraines, and Salsalate, is used to help treat the pain of osteoarthritis or rheumatoid arthritis. The company expects the revenues of newly added products to begin Q4 of 2022"

SHMN is not a distributor, and they never claimed to be....


So do you believe SOHM Inc is going to just hold on to these products orDISTRIBUTE THEIR PRIVATE LABEL PRODUCTS directly to pharmacies and other distributors to sell to pharmacies?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHMN News